We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

40 hedge funds and large institutions have $190K invested in CERo Therapeutics Warrants in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less funds holding

Funds holding: 43 → 40 (-3)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

60% less capital invested

Capital invested by funds: $478K → $190K (-$288K)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
40
Holders Change
-3
Holders Change %
-6.98%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
5
Closed
3
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
-$5K

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$4.43K
2
CS
Clear Street
New York
+$1.6K
3
FTUS
Flow Traders U.S.
New York
+$134
4
HF
HRT Financial
New York
+$9
5
Bank of America
Bank of America
North Carolina
+$6

Top Sellers

Rank Fund Capital Flow
1
BI
Bulldog Investors
New Jersey
-$3.45K
2
SCM
Shaolin Capital Management
Florida
-$2.62K
3
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
-$1.61K
4
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$172
5
RCM
Radcliffe Capital Management
Pennsylvania
-$19
Name Holding Trade Value Shares
Change 		Change in
Stake
SSA
26
Schonfeld Strategic Advisors
New York
$917 – – –
RCM
27
Rivernorth Capital Management
Florida
$750 – – –
SFM
28
Spartan Fund Management
Canada
$688 – – –
Walleye Capital
29
Walleye Capital
New York
$611 – – –
WA
30
Whitebox Advisors
Minnesota
$588 – – –
Parallax Volatility Advisers
31
Parallax Volatility Advisers
California
$399 -$172 -5,498 -27%
CSS
32
Cubist Systematic Strategies
Connecticut
$393 – – –
Calamos Advisors
33
Calamos Advisors
Illinois
$344 – – –
DCM
34
Dupont Capital Management
Delaware
$344 – – –
Walleye Trading
35
Walleye Trading
New York
$317 – – –
SRF
36
Silver Rock Financial
California
$306 – – –
ETH
37
Exos TFP Holdings
New York
$93 – – –
AA
38
Ancora Advisors
Ohio
$69 – – –
RCM
39
Robinson Capital Management
Michigan
$24 -$3 -112 -10%
Bank of America
40
Bank of America
North Carolina
$5 +$6 +200 New
CCA
41
Castle Creek Arbitrage
Colorado
– -$14.3K -200,000 Closed
BI
42
Bulldog Investors
New Jersey
– -$3.45K -48,223 Closed
CAPTRUST Financial Advisors
43
CAPTRUST Financial Advisors
North Carolina
– -$1.61K -22,432 Closed
HF
44
HRT Financial
New York
– +$9 +296 +0.8%
1
2

CEROW Hedge Fund Activity: Q4 2023 in Review

40 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q4 2023, worth a combined $190K — down 60% from $478K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CEROW and 1 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 4 added.

The largest buyer was Cowen and Company, adding an estimated $4.43K. The largest seller was Bulldog Investors, exiting entirely with an estimated $3.45K sold.

  • 40 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q4 2023, down from 43 in Q3 2023.
  • Funds reported $190K of CERo Therapeutics Warrants stock for Q4 2023, down 60% quarter-over-quarter.
  • 1 fund opened new CERo Therapeutics Warrants positions in Q4 2023 and 3 closed out, a net change of -2 holders.
  • The largest CERo Therapeutics Warrants buyer in Q4 2023 was Cowen and Company, an estimated $4.43K added.
  • The largest CERo Therapeutics Warrants seller in Q4 2023 was Bulldog Investors, an estimated $3.45K sold.

Based on aggregated 13F filings for Q4 2023.